Brooks, Moore & Associates, Inc. Merck & Co., Inc. Transaction History

Brooks, Moore & Associates, Inc.

$168 Million
Q3 2024

A detailed history of Brooks, Moore & Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brooks, Moore & Associates, Inc. holds 47,536 shares of MRK stock, worth $4.9 Million. This represents 3.2% of its overall portfolio holdings.

Number of Shares

47,536

Previous 47,130 0.86%

Holding current value

$4.9 Million

Previous $5.83 Million 7.47%

% of portfolio

3.2%

Previous 3.76%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $45,126 - $52,361	406 Added 0.86%	47,536 $5.4 Million
Q2 2024 Aug 15, 2024	SELL	$123.8 - $132.96 $48,901 - $52,519	-395 Reduced 0.83%	47,130 $5.83 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $5,548 - $6,465	-49 Reduced 0.1%	47,525 $6.27 Million
Q4 2023 Feb 15, 2024	SELL	$100.18 - $109.02 $16,830 - $18,315	-168 Reduced 0.35%	47,574 $5.19 Million
Q3 2023 Nov 15, 2023	BUY	$102.95 - $114.33 $135,070 - $150,000	1,312 Added 2.83%	47,742 $4.92 Million
Q2 2023 Aug 15, 2023	SELL	$108.61 - $118.38 $24,437 - $26,635	-225 Reduced 0.48%	46,430 $5.36 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $191,056 - $213,180	1,856 Added 4.14%	46,655 $4.96 Million
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $66,541 - $85,315	-761 Reduced 1.67%	44,799 $4.97 Million
Q3 2022 Nov 17, 2022	SELL	$84.53 - $94.96 $48,773 - $54,791	-577 Reduced 1.25%	45,560 $3.92 Million
Q2 2022 Aug 04, 2022	SELL	$83.49 - $94.64 $81,402 - $92,274	-975 Reduced 2.07%	46,137 $4.21 Million
Q1 2022 May 03, 2022	SELL	$73.51 - $82.4 $53,294 - $59,740	-725 Reduced 1.52%	47,112 $3.87 Million
Q4 2021 Feb 04, 2022	SELL	$72.28 - $90.54 $18,070 - $22,635	-250 Reduced 0.52%	47,837 $3.67 Million
Q3 2021 Nov 08, 2021	BUY	$71.68 - $78.83 $5,376 - $5,912	75 Added 0.16%	48,087 $3.61 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $440,984 - $487,773	6,272 Added 15.03%	48,012 $3.73 Million
Q1 2021 May 04, 2021	BUY	$68.86 - $81.11 $349,808 - $412,038	5,080 Added 13.86%	41,740 $3.22 Million
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $44,856 - $49,781	625 Added 1.73%	36,660 $3 Million
Q3 2020 Nov 02, 2020	SELL	$73.18 - $82.95 $45,517 - $51,594	-622 Reduced 1.7%	36,035 $2.99 Million
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $115,981 - $131,974	1,647 Added 4.7%	36,657 $2.84 Million
Q1 2020 Apr 22, 2020	SELL	$63.36 - $87.82 $31,680 - $43,910	-500 Reduced 1.41%	35,010 $2.69 Million
Q4 2019 Jan 30, 2020	BUY	$77.58 - $87.54 $89,449 - $100,933	1,153 Added 3.36%	35,510 $3.23 Million
Q3 2019 Oct 25, 2019	BUY	$76.08 - $82.93 $42,985 - $46,855	565 Added 1.67%	34,357 $2.89 Million
Q2 2019 Aug 09, 2019	BUY	$69.84 - $81.59 $62,716 - $73,267	898 Added 2.73%	33,792 $2.83 Million
Q1 2019 Apr 24, 2019	SELL	$69.58 - $79.36 $39,312 - $44,838	-565 Reduced 1.69%	32,894 $2.74 Million
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $2.18 Million - $2.53 Million	33,459 New	33,459 $2.56 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooks, Moore & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brooks, Moore & Associates, Inc. with notifications on news.

Account

Brooks, Moore & Associates, Inc. Merck & Co., Inc. Transaction History